Metastatic

Oncology
1
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sanofi
SanofiPARIS, France
1 program
1
ZD6474Phase 14 trials
Active Trials
NCT00496509Completed24Est. Oct 2007
NCT00507091Completed24Est. Jun 2008
NCT00059722Completed160Est. Jun 2007
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SanofiZD6474
SanofiZD6474
SanofiZD6474
SanofiZD6474

Clinical Trials (4)

Total enrollment: 252 patients across 4 trials

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

Start: May 2003Est. completion: Jun 2007160 patients
Phase 2Completed

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

Start: May 2002Est. completion: Nov 200344 patients
Phase 2Completed

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Start: Aug 2006Est. completion: Oct 200724 patients
Phase 1Completed

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Start: Aug 2005Est. completion: Jun 200824 patients
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space